FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079185949> ?p ?o ?g. }

• W2079185949 endingPage "183" @default.
• W2079185949 startingPage "180" @default.
• W2079185949 abstract "Cytomegalovirus infection and disease is associated with poor prognosis and steroid refractoriness in inflammatory bowel disease patients. The unfavourable effect of steroids and immunosuppressive therapy on CMV infection is well known but few data are available concerning anti-TNFalpha therapy (Infliximab). Aim of the study was to evaluate the presence and severity of CMV infection and disease in Infliximab-treated IBD patients.The severity of active CMV infection and disease was assessed in 11 consecutive patients with ileocolonic/colonic disease and 4 patients with ulcerative colitis before and after a standard 3-infusion course of Infliximab. Active CMV infection was evaluated by serology and diagnosed by means of pp65-antigenemia (pp65 AG), and quantification of CMV DNA isolated from biopsy specimens of colonic tissue. CMV disease was assessed on haematoxylin/eosin-stained colonic biopsies and immunohistochemical stains.Of the 11 patients, nine were CMV seropositive. As far as concerns CMV infection, only one patient had positive pp65 AG, before and after Infliximab. CMV DNA was detected in the colonic biopsies of three patients. In 2, CMV DNA persisted also after therapy with 410 and 1300 copies/microg of DNA, respectively, albeit with no evidence of worsening of the colonic disease. In the remaining patient, CMV DNA load became undetectable. Conventional histology and immunohistochemical stains were negative for CMV in all the patients, without evidence of CMV disease.Active CMV infection did not progress to disease following Infliximab therapy. Although these preliminary observations require confirmation, the response to Infliximab therapy does not appear to be influenced by, or influence the course of, CMV infection/disease." @default.
• W2079185949 created "2016-06-24" @default.
• W2079185949 creator A5013370793 @default.
• W2079185949 creator A5027073911 @default.
• W2079185949 creator A5034347557 @default.
• W2079185949 creator A5048837203 @default.
• W2079185949 creator A5049068984 @default.
• W2079185949 creator A5057130094 @default.
• W2079185949 creator A5062450228 @default.
• W2079185949 creator A5091201235 @default.
• W2079185949 date "2008-10-01" @default.
• W2079185949 modified "2023-10-17" @default.
• W2079185949 title "Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFα therapy" @default.
• W2079185949 cites W1965781942 @default.
• W2079185949 cites W1971273988 @default.
• W2079185949 cites W1984638982 @default.
• W2079185949 cites W1995426432 @default.
• W2079185949 cites W1998311110 @default.
• W2079185949 cites W2009606114 @default.
• W2079185949 cites W2013349323 @default.
• W2079185949 cites W2018990797 @default.
• W2079185949 cites W2061832459 @default.
• W2079185949 cites W2079426997 @default.
• W2079185949 cites W2091638250 @default.
• W2079185949 cites W2096233660 @default.
• W2079185949 cites W2162134386 @default.
• W2079185949 cites W2166930089 @default.
• W2079185949 cites W2178618034 @default.
• W2079185949 cites W3149527659 @default.
• W2079185949 cites W4254261492 @default.
• W2079185949 doi "https://doi.org/10.1016/j.jcv.2008.06.002" @default.
• W2079185949 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18614396" @default.
• W2079185949 hasPublicationYear "2008" @default.
• W2079185949 type Work @default.
• W2079185949 sameAs 2079185949 @default.
• W2079185949 citedByCount "74" @default.
• W2079185949 countsByYear W20791859492012 @default.
• W2079185949 countsByYear W20791859492013 @default.
• W2079185949 countsByYear W20791859492014 @default.
• W2079185949 countsByYear W20791859492015 @default.
• W2079185949 countsByYear W20791859492016 @default.
• W2079185949 countsByYear W20791859492017 @default.
• W2079185949 countsByYear W20791859492018 @default.
• W2079185949 countsByYear W20791859492019 @default.
• W2079185949 countsByYear W20791859492020 @default.
• W2079185949 countsByYear W20791859492021 @default.
• W2079185949 countsByYear W20791859492022 @default.
• W2079185949 countsByYear W20791859492023 @default.
• W2079185949 crossrefType "journal-article" @default.
• W2079185949 hasAuthorship W2079185949A5013370793 @default.
• W2079185949 hasAuthorship W2079185949A5027073911 @default.
• W2079185949 hasAuthorship W2079185949A5034347557 @default.
• W2079185949 hasAuthorship W2079185949A5048837203 @default.
• W2079185949 hasAuthorship W2079185949A5049068984 @default.
• W2079185949 hasAuthorship W2079185949A5057130094 @default.
• W2079185949 hasAuthorship W2079185949A5062450228 @default.
• W2079185949 hasAuthorship W2079185949A5091201235 @default.
• W2079185949 hasConcept C126322002 @default.
• W2079185949 hasConcept C159654299 @default.
• W2079185949 hasConcept C203014093 @default.
• W2079185949 hasConcept C2522874641 @default.
• W2079185949 hasConcept C2775862500 @default.
• W2079185949 hasConcept C2775934546 @default.
• W2079185949 hasConcept C2776409557 @default.
• W2079185949 hasConcept C2777138892 @default.
• W2079185949 hasConcept C2777662283 @default.
• W2079185949 hasConcept C2777732132 @default.
• W2079185949 hasConcept C2778260677 @default.
• W2079185949 hasConcept C2779134260 @default.
• W2079185949 hasConcept C2779280984 @default.
• W2079185949 hasConcept C2780479503 @default.
• W2079185949 hasConcept C2780727368 @default.
• W2079185949 hasConcept C45189115 @default.
• W2079185949 hasConcept C71924100 @default.
• W2079185949 hasConcept C90924648 @default.
• W2079185949 hasConceptScore W2079185949C126322002 @default.
• W2079185949 hasConceptScore W2079185949C159654299 @default.
• W2079185949 hasConceptScore W2079185949C203014093 @default.
• W2079185949 hasConceptScore W2079185949C2522874641 @default.
• W2079185949 hasConceptScore W2079185949C2775862500 @default.
• W2079185949 hasConceptScore W2079185949C2775934546 @default.
• W2079185949 hasConceptScore W2079185949C2776409557 @default.
• W2079185949 hasConceptScore W2079185949C2777138892 @default.
• W2079185949 hasConceptScore W2079185949C2777662283 @default.
• W2079185949 hasConceptScore W2079185949C2777732132 @default.
• W2079185949 hasConceptScore W2079185949C2778260677 @default.
• W2079185949 hasConceptScore W2079185949C2779134260 @default.
• W2079185949 hasConceptScore W2079185949C2779280984 @default.
• W2079185949 hasConceptScore W2079185949C2780479503 @default.
• W2079185949 hasConceptScore W2079185949C2780727368 @default.
• W2079185949 hasConceptScore W2079185949C45189115 @default.
• W2079185949 hasConceptScore W2079185949C71924100 @default.
• W2079185949 hasConceptScore W2079185949C90924648 @default.
• W2079185949 hasIssue "2" @default.
• W2079185949 hasLocation W20791859491 @default.
• W2079185949 hasLocation W20791859492 @default.
• W2079185949 hasOpenAccess W2079185949 @default.
• W2079185949 hasPrimaryLocation W20791859491 @default.

• next